Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 18 phantom stock units through the Pfizer Supplemental Savings Plan on August 30, 2024.

Summary

• On August 30, 2024, Albert Bourla, the Chairman & CEO of Pfizer Inc., acquired 18 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of common stock.
• These units are settled in cash following the reporting person's separation from service and may be transferred into an alternative investment account at any time.
• Following the transaction, Bourla directly owns 678,847 shares of Pfizer common stock.
• The price of the common stock was $29.01.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to executive compensation, indicating a neutral sentiment.

Positives

• The acquisition of phantom stock units through the Supplemental Savings Plan aligns the CEO's interests with those of the shareholders.

Industry Context

Executive compensation packages often include stock options or phantom stock units to incentivize performance and align executive interests with shareholder value. This filing reflects a routine transaction related to such a compensation plan.

Stakeholder Impact

• The acquisition of phantom stock units aligns the CEO's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates